NO980923L - Optisk aktivt fenylpyrimidin-derivat som analgetisk middel - Google Patents

Optisk aktivt fenylpyrimidin-derivat som analgetisk middel

Info

Publication number
NO980923L
NO980923L NO980923A NO980923A NO980923L NO 980923 L NO980923 L NO 980923L NO 980923 A NO980923 A NO 980923A NO 980923 A NO980923 A NO 980923A NO 980923 L NO980923 L NO 980923L
Authority
NO
Norway
Prior art keywords
analgesic
optically active
phenylpyrimidine derivative
active phenylpyrimidine
derivative
Prior art date
Application number
NO980923A
Other languages
English (en)
Other versions
NO980923D0 (no
Inventor
Malcolm Stuart Nobbs
Sandra Jane Rodgers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO980923D0 publication Critical patent/NO980923D0/no
Publication of NO980923L publication Critical patent/NO980923L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pyrimidin med formel (I): (I) og farmasøytisk akseptable syreaddisjonssalter derav er nyttige som analgetika, som antikonvulsjonsmidler eller ved behandling av irritabelt magesyndrom eller bipolar sykdom.
NO980923A 1995-09-05 1998-03-04 Optisk aktivt fenylpyrimidin-derivat som analgetisk middel NO980923L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9518027.9A GB9518027D0 (en) 1995-09-05 1995-09-05 Pharmacologically active compound
PCT/EP1996/003856 WO1997009317A2 (en) 1995-09-05 1996-09-03 Optically active phenyl pyrimidine derivative as analgesic agent

Publications (2)

Publication Number Publication Date
NO980923D0 NO980923D0 (no) 1998-03-04
NO980923L true NO980923L (no) 1998-05-04

Family

ID=10780172

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980923A NO980923L (no) 1995-09-05 1998-03-04 Optisk aktivt fenylpyrimidin-derivat som analgetisk middel

Country Status (32)

Country Link
US (1) US6124308A (no)
EP (1) EP0879230B1 (no)
JP (1) JPH11512108A (no)
KR (1) KR19990044397A (no)
CN (1) CN1200729A (no)
AP (1) AP640A (no)
AR (1) AR004192A1 (no)
AT (1) ATE203523T1 (no)
AU (1) AU710091B2 (no)
BG (1) BG65102B1 (no)
BR (1) BR9610388A (no)
CA (1) CA2230362A1 (no)
CO (1) CO4750651A1 (no)
CZ (1) CZ65598A3 (no)
DE (1) DE69614150T2 (no)
EA (1) EA000695B1 (no)
ES (1) ES2160834T3 (no)
GB (1) GB9518027D0 (no)
HR (1) HRP960399A2 (no)
HU (1) HUP9901260A3 (no)
ID (1) ID17274A (no)
IL (1) IL123414A0 (no)
IS (1) IS4673A (no)
NO (1) NO980923L (no)
NZ (1) NZ318390A (no)
PL (1) PL325329A1 (no)
SK (1) SK28598A3 (no)
TR (1) TR199800386T1 (no)
TW (1) TW367326B (no)
WO (1) WO1997009317A2 (no)
YU (1) YU49796A (no)
ZA (1) ZA967466B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR016212A1 (es) * 1998-04-28 2001-06-20 Astra Ab Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas
WO1999064045A1 (en) * 1998-06-08 1999-12-16 Advanced Medicine, Inc. Novel therapeutic agents for membrane transporters
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
GB9907965D0 (en) * 1999-04-09 1999-06-02 Glaxo Group Ltd Medical use
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
WO2002007822A2 (en) * 2000-07-21 2002-01-31 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
IL157608A0 (en) * 2001-02-27 2004-03-28 Teva Pharma New crystal forms of lamotrigine and processes for their preparations
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
AU2003234240A1 (en) * 2002-04-23 2003-11-10 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing lamotrigine particles of defined morphology
JP2006515326A (ja) * 2003-01-30 2006-05-25 ダイノジェン ファーマシューティカルズ， インコーポレイテッド 胃腸管障害を処置するためのナトリウムチャネルモジュレーターの使用
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
JP2010516731A (ja) 2007-01-24 2010-05-20 グラクソ グループ リミテッド ２−メトキシ−５−（５−トリフルオロメチル−テトラゾール−１−イル）−ベンジル］−（２ｓ−フェニル−ピペリジン−３ｓ−イル）−アミンを含む医薬組成物
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021121B1 (en) * 1979-06-01 1983-05-11 The Wellcome Foundation Limited 1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä

Also Published As

Publication number Publication date
SK28598A3 (en) 1998-09-09
TW367326B (en) 1999-08-21
CA2230362A1 (en) 1997-03-13
JPH11512108A (ja) 1999-10-19
HUP9901260A3 (en) 2001-04-28
IS4673A (is) 1998-02-23
TR199800386T1 (xx) 1998-05-21
KR19990044397A (ko) 1999-06-25
AP9600857A0 (en) 1996-10-31
EA199800189A1 (ru) 1998-10-29
MX9801680A (es) 1998-05-31
HUP9901260A2 (hu) 1999-09-28
HRP960399A2 (en) 1998-04-30
BR9610388A (pt) 1999-07-06
CZ65598A3 (cs) 1998-07-15
CN1200729A (zh) 1998-12-02
NO980923D0 (no) 1998-03-04
AU6986596A (en) 1997-03-27
BG65102B1 (bg) 2007-02-28
ATE203523T1 (de) 2001-08-15
WO1997009317A3 (en) 1997-04-03
AR004192A1 (es) 1998-11-04
EP0879230B1 (en) 2001-07-25
EP0879230A2 (en) 1998-11-25
AP640A (en) 1998-04-14
PL325329A1 (en) 1998-07-20
ID17274A (id) 1997-12-18
ZA967466B (en) 1998-04-06
DE69614150T2 (de) 2001-11-22
EA000695B1 (ru) 2000-02-28
WO1997009317A2 (en) 1997-03-13
US6124308A (en) 2000-09-26
DE69614150D1 (de) 2001-08-30
ES2160834T3 (es) 2001-11-16
NZ318390A (en) 1999-02-25
IL123414A0 (en) 1998-09-24
AU710091B2 (en) 1999-09-16
CO4750651A1 (es) 1999-03-31
GB9518027D0 (en) 1995-11-08
BG102342A (en) 1998-09-30
YU49796A (sh) 1999-07-28

Similar Documents

Publication Publication Date Title
BR0010220A (pt) Compostos de pirimidinona
BR0011130A (pt) Inibidores de metaloproteases
DK0741710T3 (da) Chlorpyrimidin-mellemprodukter
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
AU3475097A (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
BR0014078A (pt) Inibidores de fator xa
DK0624595T3 (da) Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
ATE290015T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen
DE69706642D1 (de) Pyridylfuran- und Pyridylthiphenderivate und deren pharmazeutische Verwendung
NO952132D0 (no) Farmakologiske aktive pyridin-derivater og deres fremstilling
NO996108L (no) 9-oksinerytromycinderivater
AU6563596A (en) Treatment of tinnitis using neuroprotective agents
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
NO954878L (no) Pyrrolderivater
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
CA2040982A1 (en) N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
BR0213994A (pt) Derivados heterocìclicos de glicinamida e seus usos médicos
SE9802208D0 (sv) Novel compounds
WO1997009317A3 (en) Optically active phenyl pyrimidine derivative as analgesic agent
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
SE9802209D0 (sv) Novel compounds
SE9504662D0 (sv) New compounds
AU2566101A (en) Compounds and methods for the treatment of pain
SE9802538D0 (sv) New pharmaceutically active compounds
PT1232173E (pt) Derivados do acido fusidico

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application